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CD46 is a cell surface protein that regulates complement activity and is utilized as a receptor by
numerous viral and bacterial pathogens that infect humans. CD46 is not just an entry site for patho-
gens, but can affect various cellular activities in response to pathogen binding that can have pro-
found consequences for the host response to infection. The study of CD46 signaling in T cells has
emerged as an exciting area of research that is shedding new light on how pathogens might manip-
ulate the host immune response. This review will focus on our current understanding of CD46 sig-
naling in T cell polarity and how this might inﬂuence disease outcome.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
CD46 is a cell surface receptor with important roles in both the
innate and adaptive immune responses. CD46 functions primarily
as a complement control protein by preventing host cell lysis by
autologous complement. However, binding of the CD46 receptor
also triggers signaling pathways that inﬂuence host cell activity.
Interestingly, a growing number of pathogenic micro-organisms
have evolved to bind to the CD46 receptor. This attraction for
CD46 by viruses and bacteria has stimulated interest in the rela-
tionship between CD46 signaling and disease. CD46 ligation by
complement or pathogens affects the biological functions of diverse
immune cells such as macrophages, dendritic cells and T cells.
Cell polarity, or the compartmentalization of proteins within a
cell, is essential in the regulation of T cell activity. In turn, efﬁcient
T cell activation is critical for an effective immune response against
pathogenic infection. Ligation of CD46 alters T cell polarity by
inducing the localization of cell signaling and adaptor proteins to
the site of CD46 cross-linking. Binding of CD46 on T cells by patho-
gens is therefore likely to impact on the immune response and dis-
ease outcome. Indeed, the effects of CD46 binding by measles virus
on T cells may be partly responsible for the immune-suppression
observed in measles patients. A thorough investigation into the
role of CD46 in T cells is essential to better understand the diseases
caused by pathogens that bind CD46. Furthermore, this knowledgechemical Societies. Published by E
aboratory, Peter MacCallum
).will be advantageous in the application of CD46 binding viruses as
oncolytic agents for cancer therapy. Here, we focus on the role of
CD46 signaling in T cell biology, with an emphasis on T cell polar-
ity, and discuss how this relates to diseases caused by pathogens
that bind to this receptor.2. CD46 is a complement regulator and pathogen receptor
CD46 is a type I membrane glycoprotein expressed by all hu-
man nucleated cells. Homologues of the CD46 gene are found in
primates, swine, mice, rats and guinea pigs. CD46 is widely ex-
pressed in humans, primates and swine, however, in mice, rats
and guinea pigs, the testis is the only organ that expresses CD46
[1], suggesting it functions primarily in reproduction in these ani-
mals. In mice and rats, the rodent protein, Crry, acts as a ubiquitous
complement regulator in place of CD46 [2]. The CD46 protein com-
prises of four tandem complement control protein (CCP) modules,
several serine–threonine–proline-rich (STP) domains, a trans-
membrane domain, and a cytoplasmic tail. Multiple isoforms are
created following alternative splicing, with two major isoforms
produced that are characterized by different cytoplasmic tails [3]
that contain signaling motifs; referred to here as Cyt1 and Cyt2.
Formerly known as membrane cofactor protein (MCP), CD46
was initially identiﬁed as a complement regulatory protein. The
complement system is a major component of the innate immune
system and protects the host against pathogenic micro-organisms.
It consists of a large group of regulatory proteins that control the
classical, lectin or alternative complement pathways. CD46 acts
as a cofactor for the protease Factor I, allowing proteolytic cleavagelsevier B.V. All rights reserved.
Fig. 1. CD46 ligation induces signaling events and changes in T cell polarity.
Ligation of CD46 by antibody cross-linking induces tyrosine phosphorylation of the
Cyt 2 tail by the Src family kinase, Lck [11] and of p120CBL and LAT; two adaptor
proteins involved in the regulation of TCR signaling [10]. Phosphorylation of the
guanine nucleotide exchange factor, Vav, also occurs upon CD46 ligation, and
induces activation of the Rho GTP-ase family protein Rac [13]. These events lead to
downstream activation of p38 mitogen-activated protein kinase (MAPK), which
most likely accounts for the increase in T cell proliferation observed in T cells co-
ligated with CD3 and CD46 [10,13]. The activation of Rac, which is involved in the
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this way it protects host cells from complement attack [4]. The
importance of CD46 in preventing excessive complement activa-
tion is highlighted by the fact that a proportion of patients with
atypical haemolytic uremic syndrome have mutations in the
CD46 gene [5].
In addition to its role as a complement regulator, CD46 is also
used as a receptor by a number of pathogens of both viral and bac-
terial origin. Proteins from at least three viruses mediate binding to
the extracellular CCP modules of CD46. These include the hemag-
glutinin protein of some strains of Measles virus (MV), the glyco-
protein H of Human Herpesvirus 6 (HHV6) and the knob protein
of various serotypes of Adenovirus. In addition, the pili of the Neis-
seria speciesNeisseria gonorrhoea andNeisseria meningitides bind to
both the CCP and STP domains to mediate attachment to host cells
[6]. Finally, Streptococcus pyogenes binds to CD46 through an inter-
action with the M protein [7] (Table 1). The relationship between
CD46 signaling and the diseases caused by these pathogens will
be addressed later.
Dependent on the context, ligation of CD46 by antibody, com-
plement, or pathogens can inﬂuence T cell signaling, proliferation
and differentiation. CD46 ligation can also alter T cell polarity
and prevent normal T cell responses to antigen presentation. As
discussed below, the mechanism by which CD46 signals are trans-
mitted in T cells, or the exact consequences for T cell fate are un-
clear, but it is likely that the interactions of CD46 with polarity
proteins, lipid rafts and cytoskeletal proteins mediate the changes
in polarity induced upon receptor ligation.
3. CD46 in T cell signaling and polarity
In order for a T cell to be activated, it must ﬁrst interact with an
antigen presenting cell (APC), where the engagement of the T cell
receptor (TCR) with cognate antigen triggers a large scale rear-
rangement of the cell. This results in localized signaling clusters
at the interface of the T cell and APC, termed an immunological
synapse (IS), and at the opposite end of the T cell – termed the dis-
tal pole complex (DPC). Numerous studies have revealed much
about the nature and components of these signaling platforms,
but the precise mechanisms by which they are focused to the site
of the external signal are not well understood. However, it is clear
that the formation of an IS involves the co-ordinated actions of sur-
face receptors, the actin and tubulin cytoskeleton, vesicular traf-
ﬁcking and polarity proteins [8].
T cell polarity is integral to these processes. Cell polarity regu-
lates both the activity of a scanning, migrating T cell and the dy-
namic changes that occur upon engagement of the TCR by
antigen presented by an APC. TCR ligation leads to two events that
are both critical to effective conjugation of the T cell with an APC,
and initiation of T cell activation. The ﬁrst involves activation of
Lymphocyte function-associated antigen 1 (LFA-1) and other inte-
grins by the TCR. LFA-1 is the major integrin on T cells and its bind-
ing by intercellular adhesion molecules (ICAMs) on the APC is a
crucial step in increasing adhesion strength to favour a stop signal
for the migrating T cells Secondly, engagement of the TCR triggersTable 1
Pathogen interactions with CD46.
Pathogen Ligand CD46 binding site
Measles virus Hemagglutinin CCP1/CCP2
Herpesvirus 6 Complex of glycoproteins CCP2/CCP3
Adenoviruses Fiber Knob CCP1/CCP2
Neisseria gonorrhoeae
Neisseria meningitidis
Type IV pilus CCP3/CCP4, STPs
Streptococcus pyogenes M protein CCP1/CCP2translocation of the microtubule organising centre (MTOC) to the
interface of the two cells. The forward movement of the MTOC is
thought to be associated with the localization of key signaling mol-
ecules involved in signal transduction to the IS. Following these
events, signaling complexes accumulate in the vicinity of the
TCR, including the Src kinase, Lck, which phosphorylates tyrosine
residues on the TCR/CD3 complex, which in turn recruits zeta-
chain-associated protein kinase 70 (ZAP70), which subsequently
phosphorylates Linker for activation of T cells (LAT). The localiza-
tion of LAT to the site of TCR ligation is a key event in the initiation
of signaling pathways leading to downstream events such as actin
polymerization, Ras activation and the transcriptional changes re-
quired for T cell activation [9].
At the molecular level, the details of CD46 signal transduction in
T cells are still being elucidated, but CD46 ligation, either alone or
in combination with TCR ligation, can trigger phosphorylation of
key signaling molecules [10,11], affect T cell proliferation [10,12]
and induce morphological changes in the cell [13] (Fig. 1). CD46
ligation can also induce changes in T cell polarity such as translo-
cation of the MTOC to the site of ligation, along with clustering of
signal molecules including the TCR/CD3 complex and polarizationregulation of actin organization and cytoskeletal rearrangements may be respon-
sible for the morphological changes (characterized by actin re-localization) also
induced in human T cells following CD3 and CD46 co-ligation [13]. Co-ligation of
CD46, along with CD3 and CD28 in CD4+ T cells leads to enhanced phosphorylation
of ZAP70 and activation of the downstream effectors ERK, JNK and p38 (not shown)
[12]. The CD46 Cyt1 tail also interacts with Dlg in epithelial cells [16], co-localises
with Dlg in T cells and is required for localization of CD46 to the T cell uropod [20].
The association of Dlg with PTA-1 (a LFA-1 binding protein) via protein 4.1 suggests
that Dlg may be part of a molecular adhesive complex that serves to cluster LFA-1
associated proteins [24]. Dlg is also found to complex with the signaling molecules
Cbl, Lck and ZAP70 following activation of T cells by CD3 and CD28 co-ligation
[23,25]. Dlg can also co-operate with both ezrin and GAKIN to co-ordinate MTOC
polarization [18,33].
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of TCR ligation that occurs when a T cell conjugates to an APC. Fur-
thermore, the changes in cell polarity induced by ligation of CD46
prevents subsequent polarization of the MTOC and signaling pro-
teins to the interface of the T cell and APC, thus preventing forma-
tion of a ‘mature’ IS. This disruption of IS formation leads to a
defect in subsequent activation and effector functions [14]. The
conﬂicting data on the stimulatory versus inhibitory effects of
CD46 ligation may therefore relate to the spatial and temporal dif-
ferences in CD46 ligation. When co-ligated together, CD46 acts as a
co-stimulatory molecule with CD3 to promote T cell proliferation
and function. Pre-ligation of CD46 on T cells by, for example, by-
stander cells expressing CD46 ligands, has inhibitory effects on
subsequent TCR ligation by an APC by redirecting the axis of polar-
ity to the site of CD46 ligation, away from the APC. This suggests a
new paradigm in which receptor signaling can compete with TCR
signaling to impair the ability of a T cell to respond effectively to
antigen presentation (Fig. 2). Indeed, the notion that ligation of
surface receptors can compete to alter polarity may explain how
a T cell prioritises and responds to the multitude of external signals
encountered during an immune response [14,15].
4. Mechanism of CD46 effects on T cell polarity and fate
4.1. Interactions with the polarity network via Dlg
Although the precise pathway regulating CD46-mediated ef-
fects on T polarity is still being elucidated, the link between
CD46 and members of the polarity complex may provide one
explanation. CD46 interacts with Discs large 4 (Dlg4, also known
as PSD-95) [16], a member of the Scribble polarity complex that
regulates mammalian epithelial apical-basal polarity [17]. Dlg1–4
are mammalian homologues of Drosophila Discs large (Dlg), and
belong to a family of scaffolding proteins called MAGUKS (mem-
brane-associated guanylate kinase homologues). These proteins
are characterized by the presence of numerous protein–protein
interaction motifs including PDZ (PSD-95/Dlg/ZO-1), SH3 (Src
homology domain 3) and GUK (guanine kinase like) domains.
Polarity proteins such as Dlg and others (including Scribble andFig. 2. CD46 signaling competes with TCR signaling to impair T cell activation and potent
(APC) results in T cell receptor (TCR) ligation and establishment of an axis of polarity. This
of the two cells, lipid raft accumulation and movement of signaling and adaptor molecule
an IS triggers the TCR signaling cascade leading to downstream T cell activation. (ii) Ligat
the MTOC to the site of CD46 ligation, along with key molecules involved in the TCR signa
pathogens such as viruses and bacteria that bind to the receptor. This redirects the axis of
of an IS. This leads to inefﬁcient T cell activation and inhibition of T cell functions. (iii)
asymmetric distribution of polarity proteins and cell fate determinants (aqua dots). The li
of polarity proteins required to regulate the localization of cell fate determinants and aatypical protein kinase C) have been implicated in T cell functions
that require highly polarized phenotypes, such as migration and IS
formation [17]. Therefore, the link between CD46 and Dlg may pro-
vide a mechanism for the translation of the CD46 signal into the
polarity changes observed in human T cells [14].
How Dlg itself might transmit signals from the CD46 receptor is
currently unknown, but evidence suggests that it may facilitate
communication between signaling and cytoskeletal proteins nor-
mally involved in IS formation. Dlg1 may co-operate with ezrin
to control the microtubule architecture at the IS, which in turn is
necessary to drive signaling microcluster dynamics [18]. Ezrin is
part of the ERM (ezrin, radixin, moesin) family of membrane-cyto-
skeletal adaptor proteins that function in T cell IS formation and
signaling [19]. Interestingly, Dlg interacts with ezrin in other cells
and the two proteins co-localize in T cells [20]. Furthermore, Dlg
regulates MTOC polarization in migrating astrocytes [21]. These
studies suggest that the movement of polarity proteins such as
Dlg to the site of CD46 ligation may also induce recruitment of
the MTOC, either directly, or via cytoskeletal adaptor proteins such
as ezrin. In neuronal cells, Dlg regulates proteins at the site of neu-
ronal synaptic signaling [22] and the transient polarization of Dlg
to the IS [23] followed by recruitment to the distal pole [20], and
its association with a number T cell signaling proteins and cyto-
skeletal proteins [23–26] suggests that it may also be important
as a scaffold in the early events of TCR signaling (Fig. 1). Dlg might
also co-ordinate alternative p38 kinase activation, leading to
downstream NFAT activation [18,25]. In light of this, diversion of
Dlg from the site of TCR ligation by CD46 may interfere with the
assembly of signaling complexes required for efﬁcient T cell activa-
tion. Only the Cyt1 isoform of CD46 induces morphological
changes and Vav phosphorylation in T cells [27] suggesting that
the interaction with Dlg, facilitated by the binding site in the
Cyt1 tail, mediates this effect.
4.2. Interaction with lipid rafts
Numerous studies have highlighted the importance of protein–
protein interactions in driving TCR signaling complex formation;
however, speciﬁc lipid-mediated interactions at the T cell plasmaially inﬂuence T cell fate. (i) The interaction of a T cell with an antigen presenting cell
involves translocation of the microtubule organising centre (MTOC) to the interface
s (represented by blue dots) to form an immunological synapse (IS). The formation of
ion of the CD46 receptor on T cells by ligands (yellow stars) induces translocation of
ling cascade and lipid raft accumulation. CD46 ligands may include complement, or
polarity away from the site of interaction with the APC, preventing proper formation
Sustained interaction of a naive T cell can lead to cell division characterized by the
gation of CD46 by ligands during asymmetric cell division may cause re-distribution
lter downstream T cell fate.
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ligation, cell surface proteins cluster into micro-domains known
also as lipid rafts. Lipid rafts are nanometre patches of highly dy-
namic membrane domains rich in cholesterol and sphingomyelin
that have been proposed to play a role in orchestrating protein
trafﬁcking and in potentiating intracellular signaling [29]. Early re-
ports on lipid rafts in IS formation were based on the analysis of
detergent-resistant micro-domains (DRMs), which has now been
superseded by more sophisticated image-based methods. Use of
the membrane polarity reporter, Laurdan, has unequivocally con-
ﬁrmed the presence of condensed raft domains at T cell activation
sites [30]. Disruption of membrane condensation at the site of TCR
ligation results in normal early TCR signaling, but with fewer TCR
complexes at the membrane, impaired actin re-modelling and inhi-
bition of late response IL-2 secretion in T cells [31].
The adaptor protein LAT is targeted to lipid rafts where it pro-
vides a docking site for other signaling molecules involved in the
TCR cascade. As CD46 aggregation leads to LAT phosphorylation,
CD46 may also be targeted to lipid rafts upon ligation. CD46 con-
tains a cysteine residue in the cytoplasmic tail that, upon palmity-
lation, may facilitate lipid raft localization of the receptor upon
ligation. CD46 has been found in rafts upon HHV6 attachment to
cells, but not in uninfected cells, suggesting that virus binding to
CD46 induces re-localization of the receptor to lipid rafts [32].
Dlg is also found in lipid rafts where it associates with the signaling
molecules Lck and ZAP70 and promotes actin polymerization and
raft assembly [26]. CD2 ligation, which also causes translocation
of Dlg to the site of receptor capping [33], also induces lipid raft
accumulation which may be important for sustained T cell signal-
ing [34]. It is therefore likely that the combination of polarity pro-
tein interactions and lipid raft assembly mediated by CD46 ligation
induces the polarization phenotype we have observed in human T
cells [14].
4.3. Asymmetric cell division
Combined, the above studies suggest that CD46 ligation can
inﬂuence both protein–protein interactions and membrane
dynamics, which is likely to have profound consequences on T cell
activation, but also downstream T cell fate. Indeed, CD46 and CD3
co-ligation on CD4+ T cells induces a suppressor cell phenotype
characterized by the secretion of large amount of IL-10, typical of
the class of adaptive regulatory cells classiﬁed as T regulatory type
1 (Tr1) cells [35]. How a naive T cell differentiates into the different
subsets required for an effective immune response is still being de-
bated in the literature. One recent theory is based on the idea that
T cells divide asymmetrically to produce two daughter cells that
have different intrinsic fates. Indeed, during sustained interaction
with an APC, T cells can divide asymmetrically to produce daughter
cells that inherit different polarity and cell fate determinants that
might impact on their differentiation [36]. In particular, CD8+ T
cells may use asymmetric cell division (ACD) to generate short-
lived ‘effector’ cells, that proliferate rapidly and kill target cells,
and ‘memory’ cells that are long lived and proliferate rapidly on
re-exposure to antigen [37]. Although the mechanisms controlling
ACD in T cells are still being investigated, polarity proteins such as
Dlg are important in maintaining polarity during division, and in
regulating the localization of cell fate determinants into daughter
cells, in many other cell types [38]. Since CD46 ligation alters T cell
polarity and inﬂuences T cell fate, it is conceivable that, by provid-
ing an alternative polarizing signal during T cell ACD, CD46 may al-
ter the segregation of cell fate determinants into the daughter cells
and skew T cell fate (Fig. 2).
In light of the diverse effects that CD46 can have on T cell sig-
naling and polarity, it is not surprising that CD46 binding patho-
gens have evolved to utilize these effects to their advantage.What the physiological relevance of this is for infectious and im-
mune diseases remains to be answered, and is discussed below.5. CD46 and pathogenic infection
5.1. Measles virus
Since the introduction of the measles vaccine in 1963, the inci-
dence of measles cases has steadily declined. However, it is still a
signiﬁcant cause of death in developing countries, with 164 000
deaths in 2008 [39]. Measles virus (MV) entry relies on the interac-
tions of the hemagglutinin (H) protein with receptors on the host
cell surface. The virus enters through the respiratory tract, and
commonly causes fever and cough, but also a severe immune-sup-
pression that can aggravate the secondary infections that predom-
inantly cause lethality. The inability of T cells to expand in
response to activation (by polyclonal or antigen speciﬁc stimulus)
ex vivo is a hallmark of measles-induced immune-suppression in
both humans and animal models. However, the low frequency of
peripheral cells infected with the virus during acute disease sug-
gests that the inhibition of cell function does not result from infec-
tion of the cells themselves, but rather from a bystander affect of
other infected cells [40].
The ﬁrst measles receptor to be identiﬁed was CD46, however,
high afﬁnity binding to CD46 is conﬁned to attenuated virus strains
whereas wild-type strains bind to the CD150 (signaling cell activa-
tion molecule SLAM) receptor. Although virus binding to these
receptors can facilitate viral entry into host cells, the above studies
demonstrate that binding to CD46 not only facilitates the spread of
infection, but can also have profound effects on the immune sys-
tem. The analysis of transgenic mice expressing individual iso-
forms of CD46 has provided the most compelling evidence that
CD46 signaling in T cells is important for measles-induced im-
mune-suppression. Using inactivated vesicular stomatitis virus
(VSV) expressing the MV hemagglutinin protein to speciﬁcally en-
gage CD46 on cells in vivo, CD46 was found to regulate the delayed
type hypersensitivity response (DTH), with differential effects
depending on which CD46 isoform was expressed. Cyt1 ligation
inhibited the T cell mediated inﬂammatory response, while Cyt2
enhanced it [27]. Immune-suppression, including inhibition of
the DTH response, is associated with measles infection and vacci-
nation [41], lending weight to the idea that engagement of CD46
by MV virus can directly suppress immune responses.
Exposure to measles virus generates a number of responses in T
cells that may reﬂect direct effects of CD46 receptor signaling. MV
exposure prevents activation of the phosphatidyl-inositol-3-kinase
(PI3K)/Akt kinase pathway after CD3/CD28 ligation, affecting
downstream T cell activation and proliferation. The regulatory sub-
unit of PI3K, p85, which acts upstream of Akt, is tyrosine phosphor-
ylated after TCR ligation in T cells exposed to MV, but fails to
redistribute to lipid rafts [42]. MV contact with T cells induces an
isoform of the phosphatase SHIP-1 (SIP110) to accumulate in lipid
rafts where it depletes phosphatidyl-inositol-3,4,5-phosphates
(PIP3), raising the threshold of TCR-dependent activation of the
cells [42]. MV signaling also interferes with activation of the gua-
nosine exchange factor, Vav, and its downstream substrates, the
small GTPases Rac and Cdc42, which impairs cytoskeletal rear-
rangements in response to TCR ligation [43]. In line with this effect
on T cell polarity, ERM protein interactions with Dlg and CD46
[18,44] may contribute to these architectural changes. Therefore,
MV binding to CD46 is likely to have consequences for the ability
of a T cell to form stable conjugates with APCs. These studies
strongly suggest that signaling triggered by binding of MV to
CD46 can impair T cell responses due to defective lipid raft assem-
bly and impaired signaling clusters at the site of TCR ligation.
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Gonorrhea is a sexually transmitted disease caused by N. gonor-
rhoea that typically does not result in protective immunity. The bac-
terium itself has also been implicated in immune-suppression by
binding to cell surface receptors and altering the balance of co-
stimulatory and co-inhibitory signals [45]. This results in suppres-
sion of CD4+ T cell proliferation and normal immune responses.
Adherence of Neisseria to epithelial cells also causes formation of
cortical plaques – structures in the host cell cortex beneath adher-
ent bacteria that contain high concentrations of cytoskeletal com-
ponents, trans-membrane receptors and other signaling proteins
[46]. PI3K and its downstream effectors, PIP3 and Akt are concen-
trated in the cell cortex beneath adherent bacteria in epithelial cells
[47]. Neisseria type I pili bind to CD46 [48] and both CD46 and ERM
proteins cluster beneath adherent Neisseria. Noticeably, only the
Cyt1 isoform was found to cluster with the ERM proteins and not
Cyt2 [49]. The Cyt1 tail sequence FTSL is also essential for the inter-
action of the PDZ domain of Dlg with CD46 in epithelial cells [16].
As Dlg can mediate indirect interactions of type I membrane pro-
teins with the actin cytoskeleton via its ability to interact with
ERM scaffolding proteins [50], it may provide the link between
CD46 binding by Neisseria and the compartmentalization of mole-
cules to the site of bacterial attachment. These studies highlight
the emerging theme that Dlg, ERM proteins and rafts co-ordinate
to translate the effects of CD46 binding into the cell polarity
changes that occur following pathogen binding.
S. pyogenes (Group A Streptococcus) is a gram negative human
pathogen that can cause mild to severe infections of the skin and
throat. An important virulence factor of S. pyogenes is the M pro-
tein, which mediates binding to CD46 on host cells [7]. Binding
of S. pyogenes to CD46 on T cells also triggers signaling pathways
that can affect T cell fate. Activation of CD46 on CD4+ T cells by
the Streptococcal M protein promotes T cell differentiation into
Tr-1 cells that secreted high levels of IL-10 and expressed high lev-
els of Granzyme B [51], consistent with what had been observed
previously for CD46 and CD3 antibody ligation [35]. The mecha-
nism behind the induction of T cell differentiation by CD46 ligand
binding remains to be determined, but may involve effects on T cell
ACD, as discussed earlier.
5.3. Complement
As mentioned earlier, the complement system is a vital compo-
nent of the innate immune response to pathogenic infection, and
consists of a complex network of plasma and membrane-associ-
ated proteins. The complement system can be activated through
three major pathways: the classical, lectin and alternative, which
all converge at the production of the C3 convertases. The genera-
tion of the C3 complement fragments, C3b and C4b, leads to the
activation of two effector arms of the complement system, result-
ing in both inﬂammation and opsonization. Opsonization, or coat-
ing of the pathogenic surface with complement components, ‘tags’
the pathogen as foreign, leading to further complement activation
which culminates in lysis of the micro-organism or infected cell via
the assembly of the membrane attack complex on the pathogenic
surface. Alternatively, opsonization of the pathogen by C3b and
C4b components leads to engagement of complement receptors
on host phagocytic cells, facilitating direct engulfment and
destruction of the pathogen [52].
In light of the highly destructive potential of the complement
system, it is not surprising that many proteins are dedicated to
the regulation of the system, to ensure appropriate and speciﬁc ly-
sis of foreign invaders. This regulation occurs on many levels, and
is in part mediated through the Factor I cleavage of C3b and C4b,
which renders them inactive and prevents non-speciﬁc lysis ofhost cells. To ensure this inactivation is appropriate, Factor I activ-
ity requires other co-factors, such as CD46, which are intrinsic
membrane proteins on host cells. Therefore, during conditions of
sustained complement activation, such as tissue injury or chronic
infection, CD46 protects against the destructive effects of comple-
ment. Since C3b and C4b represent natural ligands for CD46, bind-
ing of these components to the receptor will also have potential
implications for adaptive immunity.
Complement can modulate T cell responses during both the
effector and contraction phases of an immune response (reviewed
in [53]). Complement components can directly affect intrinsic
properties of T cells or indirectly steer T cell responses via modu-
lation of antigen presenting cells [4,54–56]. Direct modulation of
T cells may occur via complement receptors expressed on T cells,
such as CR1, however, unlike B cells, the role of complement recep-
tors in T cell biology is still unclear [53]. Binding of CD46 by C3b
dimers induces the development of T cells with a regulatory phe-
notype [35] in a similar manner to CD46 ligation by antibody
and Streptococcus M protein [51], but the effects of complement
binding on T cell polarity have yet to be elucidated. Dependent
on the context, it is likely that CD46 binding by natural ligands
or pathogenic micro-organisms, will have profound and varied
implications on T cell polarity and fate that will require further
investigations.6. CD46 and multiple sclerosis
Multiple Sclerosis (MS) results from autoimmune destruction
of the myelin surrounding nerve ﬁbres in the brain, and CD4+ T
cells play a central role in the disease. The role of Tr1 cells in
MS has recently attracted much attention. Tr1 cells play a critical
role in preventing autoimmune disease, in part due to their
secretion of the anti-inﬂammatory cytokine, IL-10. In particular,
IL-10 has been shown to be important in suppressing inﬂamma-
tion in a mouse model of MS, experimental autoimmune enceph-
alomyelitis [57]. In human MS patients, Tr1 cell function is
defective, and notably, the secretion of IL-10 by these cells is se-
verely impaired [58,59], suggesting that Tr1 function and IL-10
are important for the control of the human disease. Understand-
ing how the differentiation and homeostasis of Tr1 cells differs
between healthy individuals and MS patients is essential for
diagnosis and therapy.
Interestingly, CD46 is highly expressed at the blood brain bar-
rier [60]. Furthermore, T cells from MS patients express more
Cyt2 following activation and do not develop proper Tr1 function
following CD46 ligation [59]. Studies using transgenic mice
expressing either the Cyt1 or Cyt2 isoforms of CD46 have demon-
strated that signaling through Cyt2 is also associated with in-
creased inﬂammation and inhibition of IL-10 [27], correlative of a
defect in Tr1 development and consistent with the pathology seen
in MS patients.
HHV6 infection is also associated with development and relapse
of MS [61]. HHV6 uses CD46 to bind to and enter cells which con-
sequently triggers signaling pathways and effects mediated by
CD46 in T cells. Increasing viral load in the brain may activate T
cells through binding to the CD46 receptor. This ligation of CD46
by HHV6 would normally lead to the development of Tr1 cells
which then limit inﬂammation associated with the infection. How-
ever, in MS patients, ligation of CD46 not only results in defective
Tr1 induction, but might also predominantly activate Cyt2 signal-
ing, leading to increased inﬂammation and reduced IL-10 produc-
tion. These data, combined with the promiscuity of CD46 binding
and the effects of CD46 ligation on signaling, indicate that multiple
pathogens, including those that ﬁx complement, might inﬂuence T
cell fate and function to impact upon MS pathogenesis.
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By blocking the complement cascade, CD46 protects normal
cells against injury by activated complement, however, this can
also confer resistance to cancer cells. Each of the three complement
inhibitors (CD46, CD55 and CD59) have been reported to be up-
regulated on a variety of primary tumours such as breast, lung, li-
ver, kidney, prostate, cervical, gastric, colorectal and pancreatic
[62]. While CD46 is expressed on almost all non-transformed hu-
man cells, its expression on malignant cells is highly variable. A
number of studies have shown that many tumours express higher
levels of CD46 than the tissue from which they are derived. For
example, the expression of CD46 in primary cervical tissue was
found to show a progressive increase from normal to malignant
cells. An increased level of CD46 expression compared to normal
tissue is also found in breast, endometrial, lung and hepatoma pri-
mary tumours [62].
As CD46 expression is up-regulated on numerous human can-
cers, viruses that bind CD46, such as measles virus and adenovirus,
have been intensively investigated for their oncolytic potential in
cancer therapy. Some strains of measles virus in particular, have
been shown to have potent and selective oncolytic activity against
a broad range of tumours [63]. Clinical trials evaluating the onco-
lytic potential of MV in patients with recurrent ovarian cancer,
multiple myeloma or glioblastoma are ongoing, although these
are still a long way from being introduced into the clinic. If CD46
binding viruses are to be successful in cancer therapy, it is essential
that the effect of CD46 signaling induced by virus binding to host
cells be evaluated.8. Conclusions
There is clear evidence that binding to CD46 can inﬂuence cell
activity across a spectrum of cell types. In this review, we have fo-
cused on the role of CD46 in T cell signaling and polarity. Surface
receptors, such as CD46, that feed extracellular signals to polarity
proteinnetworksare likely tohaveprofoundeffects onboth intrinsic
T cell function and downstream immune responses to pathogenic
infection. Indeed, ligation of CD46 inﬂuences T cell signaling, prolif-
eration and fate. In addition, the generation of an axis of polarity
triggered by CD46 ligation impairs T cell responses to antigen
presentation by preventing proper formation of an IS. As polarity
proteins are emergingas key regulators of the T cell architecture that
facilitate signaling platforms, the link between CD46 and the polar-
ity protein Dlg, provides an intriguing explanation for the effects of
CD46 on T cells. Furthermore, lipid rafts may also be an important
factor in establishing the polarity associated with CD46 ligation.
The exact role of Dlg and lipid rafts in CD46-mediated polarity
changes remain to be determined, but the use of mouse T cells engi-
neered to express different isoforms andmutants of CD46will allow
the elucidation of the mechanisms involved. Evidence in the litera-
ture also suggests that the events following antibody mediated
cross-linking of CD46 on T cell polarity are mirrored by pathogenic
micro-organisms that bind to CD46. Bothmeasles virus and the bac-
terial species Neisseria and Streptococcus induce signaling and mor-
phological changes in host cells. Furthermore, the polarization of
host cells is amechanismwidelyusedbyviruses to facilitate transfer
from infected to uninfected cells. Cells infectedwith viruses such as
HIV or HTLV induce a ‘virological synapse’ on contact with target
cells, that, similar to an IS, induces MTOC recruitment and polariza-
tion of vesicles to the contact site. It is likely that this ‘polarity dis-
traction’ may prevent normal IS formation and impair T cell
responses [64]. It will be interesting to determine if the generation
of an alternate axis of polarity is a general phenomenon that can
be implied to other surface receptors that are utilized by pathogens.If so, this may provide an explanation for the immune-suppression
observed in many of these infections and associated pathologies.Acknowledgements
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